78356-17-9 Usage
Uses
Used in Research and Chemical Synthesis:
[1-(4-Tolyl)tetrazol-5-ylthio]acetic acid is utilized as a ligand in the field of research and chemical synthesis. Its ability to act as a ligand in coordination and organometallic chemistry makes it a valuable component in a variety of chemical reactions and processes, enhancing the scope of research and development in these areas.
Used in Medicinal Chemistry:
In the pharmaceutical industry, [1-(4-Tolyl)tetrazol-5-ylthio]acetic acid is used as a potential therapeutic agent. Its potential applications in medicinal chemistry are currently being explored, with a focus on its possible use in the treatment of various diseases. [1-(4-Tolyl)tetrazol-5-ylthio]acetic acid's unique properties make it a promising candidate for the development of new therapeutic strategies.
Used in the Synthesis of Organic Compounds:
[1-(4-Tolyl)tetrazol-5-ylthio]acetic acid also finds application as a building block in the synthesis of various organic compounds. Its unique structure and properties make it a valuable component in the creation of new organic molecules, further expanding its utility in the field of chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 78356-17-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,8,3,5 and 6 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 78356-17:
(7*7)+(6*8)+(5*3)+(4*5)+(3*6)+(2*1)+(1*7)=159
159 % 10 = 9
So 78356-17-9 is a valid CAS Registry Number.
78356-17-9Relevant academic research and scientific papers
TETRAZOLE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS
-
Page/Page column 35, (2011/04/25)
The invention relates to tetrazole compounds of formula (I) wherein X, Y, Z, R1, R2 and R3 are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds use as medicaments, especially as orexin receptor antagonists.
TETRAZOLE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS
-
Page/Page column 84, (2010/01/07)
The invention relates to tetrazole compounds of formula (I) wherein X, Y, Z, R1, R2 and R3 are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds use as medicaments, especially as orexin receptor antagonists.
